Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  Pluristem Therapeutics Inc.    PSTI   US72940R1023

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/29/2015 06/30/2015 07/01/2015 07/02/2015 07/06/2015 Date
2.49(c) 2.52(c) 2.51(c) 2.46(c) 2.43 Last
208 552 171 263 196 765 171 868 165 502 Volume
-2.73% +1.20% -0.40% -1.99% -1.22% Change
More quotes
Financials ($)
Sales 2015 0,38 M
EBIT 2015 -27,1 M
Net income 2015 -26,8 M
Debt 2015 -
Yield 2015 -
Sales 2016 0,30 M
EBIT 2016 -30,2 M
Net income 2016 -29,7 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 503x
Capi. / Sales 2016 635x
Capitalization 193 M
More Financials
Company
Pluristem Therapeutics, Inc. is a bio-therapeutic company, which develops standardized cell therapy products for the treatment of life threatening diseases.The company's patented PLX (PLacental eXpanded) cells drug delivery platform releases a cocktail of therapeutic proteins in response to a... 
More about the company
Surperformance© ratings of Pluristem Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on PLURISTEM THERAPEUTICS INC
06/30 PLURISTEM THERAPEUTICS : Israel's Pluristem raises $17M to bring placental stem ..
06/26 PLURISTEM THERAPEUTICS : Granted Australian Patent for 3D Cell Expansion Technol..
06/26 PLURISTEM THERAPEUTICS : Announces Pricing of Registered Direct Offering of Comm..
06/25 PLURISTEM THERAPEUTICS : Entry into a Material Definitive Agreement, Financial S..
06/03 PLURISTEM THERAPEUTICS : Awarded Grant from Israel’s Ministry of Economy f..
06/03 PLURISTEM THERAPEUTICS : Awarded Grant From Israel's Ministry of Economy for Mar..
06/02 PLURISTEM THERAPEUTICS INC. : Pluristem's PLX Cells Get Green Light for Fast Tra..
06/01 PLURISTEM THERAPEUTICS : Granted Key Cell Patents in Asia, Russia, Mexico, and I..
More news
Sector news : Biotechnology & Medical Research - NEC
04:16p ALNYLAM PHARMACEUTICALS : to Host Second Annual Summer "RNAi Roundtable" Webcast..
04:01p ALNYLAM PHARMACEUTICALS : to Host Second Annual Summer “RNAi Roundtable&rd..
07:01a ISIS PHARMACEUTICALS : Akcea Therapeutics Receives Orphan Drug Designation from ..
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
06/25 Pluristem prices equity offering
06/17 Pluristem awarded $2.9M grant to support R&D
05/28 Pluristem's PLX Cells Get Green Light For Fast Track Clinical Trials In Europ..
05/18 EMA picks Pluristem's PLX cells for accelerated approval program for critical..
05/18 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am


Comments 
Advertisement
Chart PLURISTEM THERAPEUTICS INC
Duration : Period :
Pluristem Therapeutics Inc Technical Analysis Chart | PSTI | US72940R1023 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions